Biogen

Aduhelm

Manufacturer:

Biogen

Aduhelm HCPCS:

J0172

HCPCS Code Descriptor:

Injection, aducanumab-avwa, 2 mg

Category:

J Code

Aduhelm NDCs:

64406-0102-02, 64406-0101-01

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Aduhelm:

Aduhelm is a Neurology drug manufactured by Biogen and administered via the Intravenous route of administration. The J Code: J0172 is aligned to the drug Aduhelm.

ACCESS PRICING AND MORE BY REGISTERING

J0172 Added Date:

January 1, 2022

J0172 Effective Date:

April 7, 2022

J0172 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Aduhelm billing and coding information.
Aduhelm patient assistance information can be found through Patient Access to Therapy at the URL: https://www.aduhelm.com/en-us/home/paying-for-aduhelm.html
Aduhelm prescribing information can be found at the link below:
Information regarding Aduhelm’s side effects can be found at MedlinePlus